Galectin Therapeutics Inc (GALT)

[sunspotter]

"They should be, up 1.20"

Why? GALT's own trial showed that belapectin doesn't work.

No amount of spinning by the investigators or the company itself can make a silk purse out of the sow's ear that is belapectin's performance in the NAVIGATE study where it simply failed to meet the primary endpoint.

Period.

PS if GALT's main direct and indirect shareholder, ex-CEO and founder Jim Czirr, is still hiring social media pimps to do his dirty work for him, he should probably stop. It's not helping and it's probably illegal.